Aurobindo Pharma’s analyst fair value estimate now sits near ₹1,379.96, compared with the prior figure around ₹1,366.07, reflecting only a modest reset to the price target rather than a sweeping ...

Forbes contributors publish independent expert analyses and insights. Tim Bajarin covers the tech industry’s impact on PC and ...

In this final installment of Transit Scheduling 101, we probe the purpose of a transit schedule… and when ditching one is the ...

Costco’s trade-in program lets you swap old electronics for store credit. Here’s how it works, what to expect, and whether or ...

The EU's battery regulation will require removable batteries in phones from 2027, potentially making repairs easier, ...

AI is making life easier but less alive. Why removing friction may be eroding courage, presence, and the very experiences that make us feel so human.

Motorola is betting that American smartphone buyers will pick durability and a stylus over brand prestige, as long as the ...

Underrated classics, modern twists on iconic names, or new games you've maybe never heard of, here are our picks for the board games you need to play.

In 2026, viruses are getting smarter. Instead of just being files, some can hide in your computer’s memory without leaving a ...

Apple’s long-rumored foldable iPhone is beginning to take shape in increasingly detailed leaks, and the picture that emerges ...

If you have an older Kindle, you don't have to throw it away or upgrade to keep using it. We're here to show you how to save ...

Kimberly-Clark Corporation is upgraded to Buy, offering a strong dividend yield ahead of the Kenvue merger. Learn more about ...